LukeBenjaminFletcherMD

PubMed

• A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia.
  Sudhir Manda, Bertrand M Anz 3rd, Christopher Benton, E Randolph Broun, Habte A Yimer, John S Renshaw, George Geils Jr, Jesus Berdeja, Jose Cruz, Jason M Melear, Suzan...> ;Hematological Oncology. 2024 May 1
• 10 citations
  Graft-versus-host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations.
  Laura F. Newell, Jennifer Dunlap, Ken Gatter, Grover C. Bagby, Richard D. Press, Rachel J. Cook, Luke B Fletcher, Jessica Leonard, Kelli M. Leong, Joseph S. Bubalo, Al...> ;American Journal of Transplantation. 2021 May 7
• 28 citations
  IDH Inhibitors in AML—Promise and Pitfalls
  Hannah Stowe McMurry, Luke B Fletcher, Elie Traer> ;Current Hematologic Malignancy Reports. 2021 Apr 30
• 11 citations
  Cell Death Pathways in Lymphoid Malignancies.
  Luke B Fletcher, Edward Nabrinsky, Tingting Liu, Alexey V. Danilov> ;Current Oncology Reports. 2020 Jan 27
• 19 citations
  Profile of Quizartinib for the Treatment of Adult Patients with Relapsed/Refractory FLT3-ITD-Positive Acute Myeloid Leukemia: Evidence to Date.
  Luke B Fletcher, Sunil K. Joshi, Elie Traer> ;Cancer Management and Research. 2020 Jan 8
• 1 citations
  Novel Approaches for Systemic Mastocytosis.
  Luke Fletcher, Uma Borate> ;Current Opinion in Hematology. 2019 Mar 1
• 7 citations
  HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients.
  Luke B. Fletcher, Rianne Veenstra, Eric Y. Loo, Amie E. Hwang, Imran Siddiqi, Lydia Visser, Bouke G. Hepkema, Ilja M. Nolte, Anke van den Berg, Wendy Cozen, Arjan Diep...> ;Plos One. 2017 Mar 23
• 35 citations
  The Selective Syk Inhibitor P505-15 (PRT062607) Inhibits B Cell Signaling and Function In Vitro and In Vivo and Augments the Activity of Fludarabine in Chronic Lymphoc...
  Stephen E. Spurgeon, Greg Coffey, Luke B. Fletcher, Russell T. Burke, Jeffrey W. Tyner, Brian J. Druker, Andreas Betz, Francis DeGuzman, Yvonne Pak, Dale Baker, Anjali...> ;The Journal of Pharmacology and Experimental Therapeutics. 2013 Feb 1
• 119 citations
  Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening
  Jeffrey W. Tyner, Wayne F. Yang, Armand Bankhead, Guang Fan, Luke B Fletcher, Jade Bryant, Jason M. Glover, Bill H. Chang, Stephen E. Spurgeon, William H. Fleming, Tib...> ;Cancer Research. 2013 Jan 1
• 16 citations
  CaM kinase control of AKT and LNCaP cell survival
  John M Schmitt, Samantha F Smith, Brendon Hart, Luke Fletcher> ;Journal of Cellular Biochemistry. 2011 Jan 1
• 55 citations
  MET receptor sequence variants R970C and T992I lack transforming capacity.
  Jeffrey W. Tyner, Luke B Fletcher, Ellen Q. Wang, Wayne F. Yang, Michael Rutenberg-Schoenberg, Carol Beadling, Motomi Mori, Michael Heinrich, Michael W. Deininger, Bri...> ;Cancer Research. 2010 Aug 1
• Join now to see all